Pharma Journalist - Page 457 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Adagio Therapeutics Raises $80M Series B Round to Further Advance Best-In-Class Antibodies for Coronavirus Treatment and Prevention

Forma Therapeutics Announces FT-4202 Receives Orphan Drug Designation In Europe For Treatment Of Sickle Cell Disease

ImmunityBio, NantKwest Announce Positive Interim Phase 1 Safety Data of hAd5 COVID-19 Vaccine Dose Study

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT to treat status epilepticus

Eli Lilly gets FDA EUA status for bamlanivimab to treat Covid-19

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women

Tezepelumab NAVIGATOR trial in severe, uncontrolled asthma patients meets primary endpoint

Calquence approved in the EU for the treatment of chronic lymphocytic leukaemia

Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications